Scott W. Morison's most recent trade in Corvus Pharmaceuticals Inc was a trade of 15,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 11, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Corvus Pharmaceuticals Inc | Scott W. Morison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Ideaya Biosciences Inc | Scott W. Morison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
Vera Therapeutics Inc - Or... | Scott W. Morison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 9,925 | 9,925 | - | - | Stock Option (right to buy) |